Cerecor Inc. has acquired New York biopharmaceutical company Ichorion Therapeutics for up to $26.6 million in stock. The Baltimore-based biotech closed the acquisition of Ichorion Monday. Milestonepayments, or extra fees associated with passing certain future goals, could bring the full value of the deal up by an additional $15 million in cash or stock. Ichorion, a privately held company, specializes in developing treatments for rare diseases, specifically inherited disorders that affect someone's…
from https://www.bizjournals.com/baltimore/news/2018/09/26/baltimores-cerecor-buys-new-york-biotech-for-20-8m.html?ana=RSS&s=article_search
via http://baltimorecheckbook.tumblr.com/post/178482972787
No comments:
Post a Comment